Key Takeaways
- • Protean Funds Scandinavia appointed Lydia Larsson as Investor Relations Manager to strengthen its investor communications function ahead of expanding its product suite.
- • The Stockholm-based stock-picking boutique is launching a Global Aktiesparfond later in 2026, a low-cost actively managed global equity fund designed to combine passive-like cost efficiency with active alpha generation.
- • Protean Select, the firm's opportunistic long/short equity hedge fund, has recently implemented inflow limits due to capacity constraints, while the firm simultaneously expands its long-only product offerings.
- • Larsson brings institutional investor relations experience from prior roles at Gilion (investment manager), Pareto Securities (five years as credit research analyst), and Swedbank Robur (institutional sales and client relations).
- • The new global fund will complement the existing Protetan Aktiesparfond Norden, managed by Richard Bråse, as the firm professionalizes its distributor and investor communication strategy.
Summary
Larsson joins Protean from Gilion, where she served as an investment manager focused on growth capital deployment in technology companies. She brings substantial experience in institutional investor management, having spent nearly eight years at Pareto Securities in various capacities, including five years as a credit research analyst, and earlier positions in institutional sales and client relations at Swedbank Robur. Her appointment reflects the firm's intent to professionalize investor communications and distributor relationships as it scales its product suite.
The firm is preparing to launch a Global Aktiesparfond in the fall of 2026, positioning it as a low-cost, actively managed global equity fund. This new product will leverage Protean's investment philosophy of combining passive-vehicle cost efficiency with active stock-picking alpha generation, building on the success of its existing Protean Aktiesparfond Norden, managed by Richard Bråse. The new fund launch comes as the firm's flagship hedge fund, Protean Select, approaches capacity limits, necessitating the closure of its opportunistic long/short equity vehicle to new inflows. The dual expansion—capping one product while launching another—signals the firm's strategic prioritization of long-only products while maintaining a disciplined approach to asset growth in its hedge fund operations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.